Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study have?
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study has 50 citations in the OpenAlex counts ScholarIQ stores.
When was Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study published?
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study has 2019 year in the ScholarIQ index.
What is the open-access status of Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study?
Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study has closed oa status in the ScholarIQ index.
What is the DOI of Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study?
The DOI for Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study is on the source record.
What is the PMID of Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study?
The PMID for Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study is on the source record.
What is the OpenAlex record for Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study?
The OpenAlex for Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study is on the source record.